Journal
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
Volume 28, Issue 6, Pages 1043-1053Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2014.09.002
Keywords
Gastric cancer; Gastritis; Gastritis staging; OLGA; OLGIM; Molecular pathology; Biomarkers
Categories
Funding
- Italian Association for Cancer Research (AIRC) [6421]
Ask authors/readers for more resources
Gastric cancer (GC) is the third leading cause of cancer-related death worldwide and it mostly develops in long-standing inflammatory conditions, and Helicobacter pylori-gastritis, in particular. Despite the increasing understanding of both the phenotypic alterations and the molecular mechanisms occurring during GC multi-step carcinogenesis, no reliable biomarker is available to be reliably implemented into GC secondary prevention strategies. Multidisciplinary diagnostic approaches integrating endoscopy, serology, histology and molecular profiling currently appears as the most appropriate approach for patients' stratification into different GC risk classes. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available